Some Trends in Chem(o)informatics.
暂无分享,去创建一个
[1] Philippe Manivet,et al. In silico platform for xenobiotics ADME-T pharmacological properties modeling and prediction. Part I: Beyond the reduction of animal model use. , 2009, Drug discovery today.
[2] Dimitris K. Agrafiotis,et al. Radial Clustergrams: Visualizing the Aggregate Properties of Hierarchical Clusters , 2007, J. Chem. Inf. Model..
[3] R. Cramer,et al. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.
[4] Antony J Williams,et al. Internet-based tools for communication and collaboration in chemistry. , 2008, Drug discovery today.
[5] J. Gasteiger,et al. Chemoinformatics: A Textbook , 2003 .
[6] Peter Willett,et al. A bibliometric analysis of the Journal of Molecular Graphics and Modelling. , 2007, Journal of molecular graphics & modelling.
[7] A. Hopkins,et al. Ligand efficiency: a useful metric for lead selection. , 2004, Drug discovery today.
[8] A. Hopfinger,et al. Construction of 3D-QSAR Models Using the 4D-QSAR Analysis Formalism , 1997 .
[9] Wendy A. Warr,et al. Chemical Information Management , 1992 .
[10] Alexander Golbraikh,et al. Application of predictive QSAR models to database mining: identification and experimental validation of novel anticonvulsant compounds. , 2004, Journal of medicinal chemistry.
[11] Gerald M. Maggiora,et al. On Outliers and Activity Cliffs-Why QSAR Often Disappoints , 2006, J. Chem. Inf. Model..
[12] Aniko Simon,et al. eHiTS: a new fast, exhaustive flexible ligand docking system. , 2007, Journal of molecular graphics & modelling.
[13] Peter Willett,et al. Similarity methods in chemoinformatics , 2009, Annu. Rev. Inf. Sci. Technol..
[14] Simone Teufel,et al. Annotation of Chemical Named Entities , 2007, BioNLP@ACL.
[15] Peter Murray-Rust,et al. Chemistry for everyone , 2008, Nature.
[16] Douglas M. Hawkins,et al. The Problem of Overfitting , 2004, J. Chem. Inf. Model..
[17] A. H. Lipkus,et al. Structural Diversity of Organic Chemistry. a Scaffold Analysis of the Cas Registry , 2022 .
[18] Gerhard Klebe,et al. Comparison of Automatic Three-Dimensional Model Builders Using 639 X-ray Structures , 1994, J. Chem. Inf. Comput. Sci..
[19] H. Berman. The Protein Data Bank: a historical perspective. , 2008, Acta crystallographica. Section A, Foundations of crystallography.
[20] Luhua Lai,et al. Further development and validation of empirical scoring functions for structure-based binding affinity prediction , 2002, J. Comput. Aided Mol. Des..
[21] Ramana Rao,et al. A focus+context technique based on hyperbolic geometry for visualizing large hierarchies , 1995, CHI '95.
[22] Yvonne C. Martin,et al. MENTHOR, a database system for the storage and retrieval of three-dimensional molecular structures and associated data searchable by substructural, biologic, physical, or geometric properties , 1988, J. Comput. Aided Mol. Des..
[23] Rajarshi Guha,et al. Structure-Activity Landscape Index: Identifying and Quantifying Activity Cliffs , 2008, J. Chem. Inf. Model..
[24] Robert P. Sheridan,et al. Protocols for Bridging the Peptide to Nonpeptide Gap in Topological Similarity Searches , 2001, J. Chem. Inf. Comput. Sci..
[25] J. A. Grant,et al. A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction. , 2005, Journal of medicinal chemistry.
[26] Tudor I. Oprea,et al. Optimization of CAMD techniques 3. Virtual screening enrichment studies: a help or hindrance in tool selection? , 2008, J. Comput. Aided Mol. Des..
[27] N. Null. The IUPAC International Chemical Identifier (InChI) , 2009 .
[28] Debra L. Banville,et al. Chemical information mining : facilitating literature-based discovery , 2008 .
[29] Stefan Wetzel,et al. The Scaffold Tree - Visualization of the Scaffold Universe by Hierarchical Scaffold Classification , 2007, J. Chem. Inf. Model..
[30] Yi Li,et al. In silico ADME/Tox: why models fail , 2003, J. Comput. Aided Mol. Des..
[31] Brian K Shoichet,et al. Prediction of protein-ligand interactions. Docking and scoring: successes and gaps. , 2006, Journal of medicinal chemistry.
[32] Tudor I. Oprea,et al. The Design of Leadlike Combinatorial Libraries. , 1999, Angewandte Chemie.
[33] Robin Taylor,et al. Comparing protein–ligand docking programs is difficult , 2005, Proteins.
[34] Alexander Tropsha,et al. Recent Trends in Quantitative Structure‐Activity Relationships , 2003 .
[35] Robert P. Sheridan,et al. Comparison of Topological, Shape, and Docking Methods in Virtual Screening , 2007, J. Chem. Inf. Model..
[36] David Weininger,et al. SMILES. 2. Algorithm for generation of unique SMILES notation , 1989, J. Chem. Inf. Comput. Sci..
[37] Jürgen Bajorath,et al. Molecular similarity analysis uncovers heterogeneous structure-activity relationships and variable activity landscapes. , 2007, Chemistry & biology.
[38] J. Gasteiger,et al. Computer-assisted reaction prediction and synthesis design , 1990 .
[39] R. Glen,et al. Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. , 1995, Journal of molecular biology.
[40] C. Lemmen,et al. FLEXS: a method for fast flexible ligand superposition. , 1998, Journal of medicinal chemistry.
[41] Bob McMeeking,et al. The United Kingdom Chemical Database Service: CDS , 2004 .
[42] David Bawden,et al. Pharmacophoric pattern matching in files of 3d chemical structures: evaluation of search performance , 1987 .
[43] Alexander Golbraikh,et al. Predictive QSAR modeling workflow, model applicability domains, and virtual screening. , 2007, Current pharmaceutical design.
[44] W. Todd Wipke,et al. STEREOCHEMICALLY UNIQUE NAMING ALGORITHM , 1974 .
[45] Frank H. Allen,et al. The Cambridge Crystallographic Database , 2007 .
[46] James Dugundji,et al. An algebraic model of constitutional chemistry as a basis for chemical computer programs , 1973 .
[47] Valerie J. Gillet,et al. Knowledge-Based Approach to de Novo Design Using Reaction Vectors , 2009, J. Chem. Inf. Model..
[48] Jürgen Bajorath,et al. Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches. , 2007, Drug discovery today.
[49] Peter Willett,et al. A bibliometric analysis of the literature of chemoinformatics , 2008, Aslib Proc..
[50] Alexander Golbraikh,et al. Rational selection of training and test sets for the development of validated QSAR models , 2003, J. Comput. Aided Mol. Des..
[51] Daniel A Erlanson,et al. Tethering: fragment-based drug discovery. , 2004, Annual review of biophysics and biomolecular structure.
[52] Steven L. Teig,et al. Chemical Function Queries for 3D Database Search , 1994, J. Chem. Inf. Comput. Sci..
[53] Dimitris K. Agrafiotis,et al. A Geodesic Framework for Analyzing Molecular Similarities , 2003, J. Chem. Inf. Comput. Sci..
[54] Andrew R. Leach,et al. An Introduction to Chemoinformatics , 2003 .
[55] Jun Feng,et al. PharmID: Pharmacophore Identification Using Gibbs Sampling , 2006, J. Chem. Inf. Model..
[56] Alain Calvet,et al. Molecular Property eXplorer: A Novel Approach to Visualizing SAR Using Tree-Maps and Heatmaps , 2005, J. Chem. Inf. Model..
[57] Gerald M. Maggiora,et al. Hierarchical Strategy for Identifying Active Chemotype Classes in Compound Databases , 2006, Chemical biology & drug design.
[58] Yvonne C. Martin,et al. Use of Structure-Activity Data To Compare Structure-Based Clustering Methods and Descriptors for Use in Compound Selection , 1996, J. Chem. Inf. Comput. Sci..
[59] Wendy A. Warr,et al. Fragment-based drug discovery , 2009, J. Comput. Aided Mol. Des..
[60] Olga Kennard,et al. Cambridge Crystallographic Data Centre. I. Bibliographic File. , 1972 .
[61] F. Allen. The Cambridge Structural Database: a quarter of a million crystal structures and rising. , 2002, Acta crystallographica. Section B, Structural science.
[62] Brian K. Shoichet,et al. ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..
[63] Paola Gramatica,et al. The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models , 2003 .
[64] Tudor I. Oprea,et al. Chemoinformatics in drug discovery , 2005 .
[65] Robert P. Sheridan,et al. Similarity to Molecules in the Training Set Is a Good Discriminator for Prediction Accuracy in QSAR , 2004, J. Chem. Inf. Model..
[66] Imre G. Csizmadia,et al. Validation of the SPROUT de novo design program , 2003 .
[67] Ajay N. Jain,et al. Ligand-based structural hypotheses for virtual screening. , 2004, Journal of medicinal chemistry.
[68] A. Ghose,et al. Knowledge-based chemoinformatic approaches to drug discovery. , 2006, Drug discovery today.
[69] J. T. Metz,et al. Ligand efficiency indices as guideposts for drug discovery. , 2005, Drug discovery today.
[70] P. Hajduk,et al. Discovering High-Affinity Ligands for Proteins: SAR by NMR , 1996, Science.
[71] Ingo Muegge,et al. Advances in virtual screening , 2006, Drug Discovery Today: Technologies.
[72] J M Blaney,et al. A geometric approach to macromolecule-ligand interactions. , 1982, Journal of molecular biology.
[73] M. Congreve,et al. Recent developments in fragment-based drug discovery. , 2008, Journal of medicinal chemistry.
[74] Bernd Wendt,et al. Pushing the boundaries of 3D-QSAR , 2007, J. Comput. Aided Mol. Des..
[75] Matthew T Stahl. Open-source software: not quite endsville. , 2005, Drug discovery today.
[76] Takayuki Itoh,et al. Visualization of Large-Scale Aqueous Solubility Data Using a Novel Hierarchical Data Visualization Technique , 2006, J. Chem. Inf. Model..
[77] John W. Liebeschuetz,et al. Evaluating docking programs: keeping the playing field level , 2008, J. Comput. Aided Mol. Des..
[78] G. Klebe. Virtual ligand screening: strategies, perspectives and limitations , 2006, Drug Discovery Today.
[79] Rob Leurs,et al. Transforming fragments into candidates: small becomes big in medicinal chemistry. , 2009, Drug discovery today.
[80] Tudor I. Oprea,et al. Is There a Difference between Leads and Drugs? A Historical Perspective , 2001, J. Chem. Inf. Comput. Sci..
[81] Gareth Jones,et al. A genetic algorithm for flexible molecular overlay and pharmacophore elucidation , 1995, J. Comput. Aided Mol. Des..
[82] J. Gasteiger,et al. Autocorrelation of Molecular Surface Properties for Modeling Corticosteroid Binding Globulin and Cytosolic Ah Receptor Activity by Neural Networks , 1995 .
[83] Peter Willett,et al. GALAHAD: 1. Pharmacophore identification by hypermolecular alignment of ligands in 3D , 2006, J. Comput. Aided Mol. Des..
[84] Christopher I. Bayly,et al. Evaluating Virtual Screening Methods: Good and Bad Metrics for the "Early Recognition" Problem , 2007, J. Chem. Inf. Model..
[85] W. Delano. The case for open-source software in drug discovery. , 2005, Drug discovery today.
[86] Pierre Benichou,et al. Handling Genericity in Chemical Structures Using the Markush Darc Software , 1997, J. Chem. Inf. Comput. Sci..
[87] Paul Watson,et al. Virtual Screening Using Protein-Ligand Docking: Avoiding Artificial Enrichment , 2004, J. Chem. Inf. Model..
[88] Christopher R. Corbeil,et al. Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go , 2008, British journal of pharmacology.
[89] Jeremy L. Jenkins,et al. Clustering and Rule-Based Classifications of Chemical Structures Evaluated in the Biological Activity Space , 2007, J. Chem. Inf. Model..
[90] Lars Ridder,et al. SyGMa: Combining Expert Knowledge and Empirical Scoring in the Prediction of Metabolites , 2008, ChemMedChem.
[91] J. Gasteiger,et al. Automatic generation of 3D-atomic coordinates for organic molecules , 1990 .
[92] J C Baber,et al. Predicting synthetic accessibility: application in drug discovery and development. , 2004, Mini reviews in medicinal chemistry.
[93] Dimitris K Agrafiotis,et al. SAR maps: a new SAR visualization technique for medicinal chemists. , 2007, Journal of medicinal chemistry.
[94] Hans-Joachim Böhm,et al. The computer program LUDI: A new method for the de novo design of enzyme inhibitors , 1992, J. Comput. Aided Mol. Des..
[95] Antony J. Williams,et al. A perspective of publicly accessible/open-access chemistry databases. , 2008, Drug discovery today.
[96] Jean-Louis Reymond,et al. Virtual Exploration of the Chemical Universe up to 11 Atoms of C, N, O, F: Assembly of 26.4 Million Structures (110.9 Million Stereoisomers) and Analysis for New Ring Systems, Stereochemistry, Physicochemical Properties, Compound Classes, and Drug Discovery , 2007, J. Chem. Inf. Model..
[97] Thomas Lengauer,et al. A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.
[98] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[99] Markus A Lill,et al. Multi-dimensional QSAR in drug discovery. , 2007, Drug discovery today.
[100] Bin Chen,et al. Gaining Insight into Off-Target Mediated Effects of Drug Candidates with a Comprehensive Systems Chemical Biology Analysis , 2009, J. Chem. Inf. Model..
[101] Patrick Marichal,et al. Data reduction and representation in drug discovery. , 2007, Drug discovery today.
[102] Andrew Smellie. General Purpose Interactive Physico-Chemical Property Exploration , 2007, J. Chem. Inf. Model..
[103] R. Clark. Prospective ligand- and target-based 3D QSAR: state of the art 2008. , 2009, Current topics in medicinal chemistry.
[104] H. L. Morgan. The Generation of a Unique Machine Description for Chemical Structures-A Technique Developed at Chemical Abstracts Service. , 1965 .
[105] Ajay N. Jain. Bias, reporting, and sharing: computational evaluations of docking methods , 2008, J. Comput. Aided Mol. Des..
[106] W. L. Jorgensen,et al. CAMEO: a program for the logical prediction of the products of organic reactions , 1990 .
[107] Jonathan W. Essex,et al. Bringing Chemical Data onto the Semantic Web , 2006, J. Chem. Inf. Model..
[108] Jürgen Bajorath,et al. Chemoinformatics : concepts, methods, and tools for drug discovery , 2004 .
[109] Stephen R. Johnson,et al. The Trouble with QSAR (or How I Learned To Stop Worrying and Embrace Fallacy) , 2008, J. Chem. Inf. Model..
[110] A. Peter Johnson,et al. CLiDE Pro: The Latest Generation of CLiDE, a Tool for Optical Chemical Structure Recognition , 2009, J. Chem. Inf. Model..
[111] Peter Willett,et al. Chemoinformatics Research at the University of Sheffield: A History and Citation Analysis , 2003, J. Inf. Sci..
[112] Sophia Ananiadou,et al. Text mining and its potential applications in systems biology. , 2006, Trends in biotechnology.
[113] Paola Gramatica,et al. Validated QSAR Prediction of OH Tropospheric Degradation of VOCs: Splitting into Training-Test Sets and Consensus Modeling , 2004, J. Chem. Inf. Model..
[114] Igor V. Filippov,et al. Optical Structure Recognition Software To Recover Chemical Information: OSRA, An Open Source Solution , 2009, J. Chem. Inf. Model..
[115] Niklas Blomberg,et al. Design of compound libraries for fragment screening , 2009, J. Comput. Aided Mol. Des..
[116] P. Hawkins,et al. Comparison of shape-matching and docking as virtual screening tools. , 2007, Journal of medicinal chemistry.
[117] T. Kennedy. Managing the drug discovery/development interface , 1997 .
[118] Markus Wagener,et al. Potential Drugs and Nondrugs: Prediction and Identification of Important Structural Features , 2000, J. Chem. Inf. Comput. Sci..
[119] Alfonso Valencia,et al. Text-mining approaches in molecular biology and biomedicine. , 2005, Drug discovery today.
[120] Mark T. D. Cronin,et al. Predicting Chemical Toxicity and Fate , 2004 .
[121] Robert D. Clark,et al. Managing bias in ROC curves , 2008, J. Comput. Aided Mol. Des..
[122] Peter Willett,et al. Maximum common subgraph isomorphism algorithms for the matching of chemical structures , 2002, J. Comput. Aided Mol. Des..
[123] Naomi L Kruhlak,et al. Combined Use of MC4PC, MDL-QSAR, BioEpisteme, Leadscope PDM, and Derek for Windows Software to Achieve High-Performance, High-Confidence, Mode of Action–Based Predictions of Chemical Carcinogenesis in Rodents , 2008, Toxicology mechanisms and methods.
[124] Osman F. Güner,et al. Pharmacophore perception, development, and use in drug design , 2000 .
[125] Anthony Nicholls,et al. What do we know and when do we know it? , 2008, J. Comput. Aided Mol. Des..
[126] Klaus-Robert Müller,et al. A Probabilistic Approach to Classifying Metabolic Stability , 2008, J. Chem. Inf. Model..
[127] Thierry Langer,et al. Molecule-pharmacophore superpositioning and pattern matching in computational drug design. , 2008, Drug discovery today.
[128] Rajarshi Guha,et al. Assessing How Well a Modeling Protocol Captures a Structure-Activity Landscape , 2008, J. Chem. Inf. Model..
[129] Dimitris K. Agrafiotis,et al. Enhanced SAR Maps: Expanding the Data Rendering Capabilities of a Popular Medicinal Chemistry Tool , 2009, J. Chem. Inf. Model..
[130] Yvonne C. Martin,et al. ALADDIN: An integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching of three-dimensional molecular structures , 1989, J. Comput. Aided Mol. Des..
[131] John J. Irwin,et al. Community benchmarks for virtual screening , 2008, J. Comput. Aided Mol. Des..
[132] A. Tropsha,et al. Beware of q2! , 2002, Journal of molecular graphics & modelling.
[133] Peter Willett,et al. Selection of screens for three-dimensional substructure searching , 1990 .
[134] Holger Claussen,et al. Second-generation de novo design: a view from a medicinal chemist perspective , 2009, J. Comput. Aided Mol. Des..
[135] Wendy A. Warr,et al. Social software: fun and games, or business tools? , 2008, J. Inf. Sci..
[136] P. Sprague. Automated chemical hypothesis generation and database searching with Catalyst , 1995 .
[137] Lee Harland,et al. Lowering industry firewalls: pre-competitive informatics initiatives in drug discovery , 2009, Nature Reviews Drug Discovery.
[138] C. Gregory,et al. Chapter V.3. Databases of Chemical Structures , 2008 .
[139] Egon L. Willighagen,et al. The Blue Obelisk—Interoperability in Chemical Informatics , 2006, J. Chem. Inf. Model..
[140] Roderick E. Hubbard,et al. Lessons for fragment library design: analysis of output from multiple screening campaigns , 2009, J. Comput. Aided Mol. Des..
[141] Yvonne C. Martin,et al. A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists , 1993, J. Comput. Aided Mol. Des..
[142] Andreas Zell,et al. Locating Biologically Active Compounds in Medium-Sized Heterogeneous Datasets by Topological Autocorrelation Vectors: Dopamine and Benzodiazepine Agonists , 1996, J. Chem. Inf. Comput. Sci..
[143] David A. Winkler,et al. The role of quantitative structure-activity relationships (QSAR) in biomolecular discovery , 2002, Briefings Bioinform..
[144] G. Klebe,et al. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. , 1994, Journal of medicinal chemistry.
[145] John Bradshaw,et al. The Effectiveness of Reactant Pools for Generating Structurally-Diverse Combinatorial Libraries , 1997, J. Chem. Inf. Comput. Sci..
[146] Peter Willett,et al. From chemical documentation to chemoinformatics: 50 years of chemical information science , 2008, J. Inf. Sci..
[147] David Weininger,et al. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules , 1988, J. Chem. Inf. Comput. Sci..
[148] Yang Liu,et al. Route Designer: A Retrosynthetic Analysis Tool Utilizing Automated Retrosynthetic Rule Generation , 2009, J. Chem. Inf. Model..
[149] H. Kubinyi,et al. A scoring scheme for discriminating between drugs and nondrugs. , 1998, Journal of medicinal chemistry.
[150] José L. Medina-Franco,et al. Characterization of Activity Landscapes Using 2D and 3D Similarity Methods: Consensus Activity Cliffs , 2009, J. Chem. Inf. Model..
[151] Qiang Zhang,et al. Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: ranking, voting, and consensus scoring. , 2006, Journal of medicinal chemistry.
[152] John M. Barnard,et al. Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..
[153] Robert J. Jilek,et al. Topomers: A Validated Protocol for Their Self-Consistent Generation , 2004, J. Chem. Inf. Model..
[154] Diane Joseph-McCarthy. Challenges of fragment screening , 2009, J. Comput. Aided Mol. Des..
[155] Ajay N. Jain,et al. Recommendations for evaluation of computational methods , 2008, J. Comput. Aided Mol. Des..
[156] P. Willett,et al. Pharmacophoric pattern matching in files of 3d chemical structures: comparison of geometric searching algorithms , 1987 .
[157] William Lingran Chen,et al. Chemoinformatics: Past, Present, and Future† , 2006, J. Chem. Inf. Model..
[158] Christian Blaschke,et al. Status of text-mining techniques applied to biomedical text. , 2006, Drug discovery today.
[159] E J Corey,et al. Computer-assisted design of complex organic syntheses. , 1969, Science.
[160] John M. Barnard. A comparison of different approaches to Markush structure handling , 1991, J. Chem. Inf. Comput. Sci..
[161] Andrew R. Leach,et al. A comparison of the pharmacophore identification programs: Catalyst, DISCO and GASP , 2002, J. Comput. Aided Mol. Des..
[162] J. Irwin,et al. Benchmarking sets for molecular docking. , 2006, Journal of medicinal chemistry.
[163] M. Congreve,et al. A 'rule of three' for fragment-based lead discovery? , 2003, Drug discovery today.
[164] Valerie J. Gillet,et al. Generation of multiple pharmacophore hypotheses using multiobjective optimisation techniques , 2004, J. Comput. Aided Mol. Des..
[165] R. Cramer,et al. Topomer CoMFA: a design methodology for rapid lead optimization. , 2003, Journal of medicinal chemistry.
[166] D. Banville. Mining chemical structural information from the drug literature. , 2006, Drug discovery today.
[167] Johann Gasteiger,et al. Ligand-Based Models for the Isoform Specificity of Cytochrome P450 3A4, 2D6, and 2C9 Substrates , 2007, J. Chem. Inf. Model..
[168] Johann Gasteiger,et al. Assessing Similarity and Diversity of Combinatorial Libraries by Spatial Autocorrelation Functions and Neural Networks , 1996 .
[169] G. Bemis,et al. The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.
[170] Manuela Pavan,et al. Review of QSAR Models for Ready Biodegradation , 2006 .
[171] Valerie J. Gillet,et al. Incorporating partial matches within multiobjective pharmacophore identification , 2006, J. Comput. Aided Mol. Des..
[172] P Willett,et al. Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.
[173] Carlos A.M. Fraga,et al. Molecular Design: Concepts and Applications , 2008 .
[174] Tudor I. Oprea,et al. Systems chemical biology. , 2007 .
[175] Philip N. Judson,et al. Using Absolute and Relative Reasoning in the Prediction of the Potential Metabolism of Xenobiotics , 2003, J. Chem. Inf. Comput. Sci..
[176] Huafeng Xu,et al. A self-organizing principle for learning nonlinear manifolds , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[177] W. L. Jorgensen. The Many Roles of Computation in Drug Discovery , 2004, Science.
[178] Jeremy G Frey,et al. The value of the Semantic Web in the laboratory. , 2009, Drug discovery today.
[179] C. Gregory Paris,et al. Chemical Structure Handling by Computer. , 1997 .
[180] Karen N. Allen,et al. An Experimental Approach to Mapping the Binding Surfaces of Crystalline Proteins , 1996 .
[181] Z. Deng,et al. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions. , 2004, Journal of medicinal chemistry.
[182] Arthur M. Doweyko,et al. 3D-QSAR illusions , 2004, J. Comput. Aided Mol. Des..
[183] Johann Gasteiger,et al. Structure and reaction based evaluation of synthetic accessibility , 2007, J. Comput. Aided Mol. Des..
[184] Lorenz C. Blum,et al. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13. , 2009, Journal of the American Chemical Society.
[185] J. Bajorath,et al. SAR index: quantifying the nature of structure-activity relationships. , 2007, Journal of medicinal chemistry.
[186] H. Kubinyi,et al. Three-dimensional quantitative similarity-activity relationships (3D QSiAR) from SEAL similarity matrices. , 1998, Journal of medicinal chemistry.
[187] William L. Jorgensen,et al. QSAR/QSPR and Proprietary Data , 2006, Journal of Chemical Information and Modeling.
[188] T Abshear,et al. A model validation and consensus building environment , 2006, SAR and QSAR in environmental research.
[189] Ben Shneiderman,et al. Tree visualization with tree-maps: 2-d space-filling approach , 1992, TOGS.
[190] Peter T. Corbett,et al. Semantic enrichment of journal articles using chemical named entity recognition , 2007, ACL.
[191] Dimitris K. Agrafiotis,et al. Stochastic proximity embedding , 2003, J. Comput. Chem..
[192] Henry S Rzepa,et al. Enhancement of the chemical semantic web through the use of InChI identifiers. , 2005, Organic & biomolecular chemistry.
[193] Andrew R. Leach,et al. Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery , 2001, J. Chem. Inf. Comput. Sci..
[194] Yvonne C. Martin,et al. The Information Content of 2D and 3D Structural Descriptors Relevant to Ligand-Receptor Binding , 1997, J. Chem. Inf. Comput. Sci..
[195] Richard A. Lewis,et al. Three-dimensional pharmacophore methods in drug discovery. , 2010, Journal of medicinal chemistry.
[196] P. Leeson,et al. The influence of drug-like concepts on decision-making in medicinal chemistry , 2007, Nature Reviews Drug Discovery.
[197] Peter Willett,et al. Alignment of three-dimensional molecules using an image recognition algorithm. , 2004, Journal of molecular graphics & modelling.
[198] Romualdo Benigni,et al. Quantitative Structure-Activity Relationship (QSAR) Models of Mutagens and Carcinogens , 2003 .
[199] Peter Willett,et al. Pharmacophoric pattern matching in files of 3-D chemical structures: election of interatomic distance screens , 1986 .
[200] Scott Boyer,et al. Reaction Site Mapping of Xenobiotic Biotransformations , 2007, J. Chem. Inf. Model..
[201] Bohdan Waszkowycz,et al. Towards improving compound selection in structure-based virtual screening. , 2008, Drug discovery today.
[202] Sean Ekins,et al. Computational mapping tools for drug discovery. , 2009, Drug discovery today.
[203] William L Jorgensen,et al. From docking false-positive to active anti-HIV agent. , 2007, Journal of medicinal chemistry.
[204] William L Jorgensen,et al. Efficient drug lead discovery and optimization. , 2009, Accounts of chemical research.
[205] Judith C. Madden,et al. Consensus QSAR Models: Do the Benefits Outweigh the Complexity? , 2007, J. Chem. Inf. Model..
[206] A. Johnson,et al. Molecular complexity analysis of de novo designed ligands. , 2006, Journal of medicinal chemistry.
[207] Kazuhiro Saitou,et al. Automated extraction of chemical structure information from digital raster images , 2009, Chemistry Central journal.
[208] Stuart L. Schreiber,et al. Chemical biology : from small molecules to systems biology and drug design , 2007 .
[209] Christopher W Murray,et al. Fragment-based lead discovery: leads by design. , 2005, Drug discovery today.
[210] D C Spellmeyer,et al. Measuring diversity: experimental design of combinatorial libraries for drug discovery. , 1995, Journal of medicinal chemistry.
[211] F. H. Allen,et al. Cambridge Crystallographic Data Centre. II. Structural Data File , 1973 .
[212] P. Hajduk,et al. A decade of fragment-based drug design: strategic advances and lessons learned , 2007, Nature Reviews Drug Discovery.
[213] Peter Willett,et al. Similarity-based virtual screening using 2D fingerprints. , 2006, Drug discovery today.
[214] Paola Gramatica,et al. Principles of QSAR models validation: internal and external , 2007 .
[215] Thomas Engel,et al. Basic Overview of Chemoinformatics , 2006, J. Chem. Inf. Model..